메뉴 건너뛰기




Volumn 12, Issue 8, 2014, Pages

Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases

Author keywords

CCFA; Patient Management; Patient Reported Outcomes; Symptoms

Indexed keywords

PREDNISONE; ADALIMUMAB; AZATHIOPRINE; CERTOLIZUMAB PEGOL; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; NATALIZUMAB; SALAZOSULFAPYRIDINE;

EID: 84904384511     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.10.019     Document Type: Article
Times cited : (154)

References (19)
  • 1
    • 84876309049 scopus 로고    scopus 로고
    • Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population
    • Kappelman M.D., Moore K.R., Allen J.K., et al. Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 2013, 58:519-525.
    • (2013) Dig Dis Sci , vol.58 , pp. 519-525
    • Kappelman, M.D.1    Moore, K.R.2    Allen, J.K.3
  • 3
    • 85101436911 scopus 로고    scopus 로고
    • Patient-reported outcomes. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Chapter 17. Version 5.0.1. The Cochrane Collaboration, 2008 Available at: .
    • Patrick D, Guyatt G, Acquadro C. Patient-reported outcomes. In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions. Chapter 17. Version 5.0.1. The Cochrane Collaboration, 2008 Available at: http://handbook.cochrane.org/.
    • Patrick, D.1    Guyatt, G.2    Acquadro, C.3
  • 4
    • 84904406235 scopus 로고    scopus 로고
    • US Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. December 2009 Available at: Accessed December 18, 2013.
    • US Department of Health and Human Services Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. December 2009 Available at: Accessed December 18, 2013. http://www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
  • 5
    • 34247360479 scopus 로고    scopus 로고
    • Developing the Patient-Reported Outcomes Measurement Information System (PROMIS)
    • Adler D. Developing the Patient-Reported Outcomes Measurement Information System (PROMIS). Med Care 2007, 45(Suppl 1):S1-S2.
    • (2007) Med Care , vol.45 , Issue.SUPPL. 1
    • Adler, D.1
  • 6
    • 34247361269 scopus 로고    scopus 로고
    • The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH roadmap cooperative group during its first two years
    • Cella D., Yount S., Rothrock N., et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care 2007, 45:S3-S11.
    • (2007) Med Care , vol.45
    • Cella, D.1    Yount, S.2    Rothrock, N.3
  • 7
    • 84861862784 scopus 로고    scopus 로고
    • Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA partners): methodology and initial results
    • Long M.D., Kappelman M.D., Martin C.F., et al. Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA partners): methodology and initial results. Inflamm Bowel Dis 2012, 18:2099-2106.
    • (2012) Inflamm Bowel Dis , vol.18 , pp. 2099-2106
    • Long, M.D.1    Kappelman, M.D.2    Martin, C.F.3
  • 8
    • 77956957760 scopus 로고    scopus 로고
    • Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)
    • Rothrock N.E., Hays R.D., Spritzer K., et al. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). JClin Epidemiol 2010, 63:1195-1204.
    • (2010) JClin Epidemiol , vol.63 , pp. 1195-1204
    • Rothrock, N.E.1    Hays, R.D.2    Spritzer, K.3
  • 9
    • 79953292342 scopus 로고    scopus 로고
    • Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-cancer scales in advanced-stage cancer patients
    • Yost K.J., Eton D.T., Garcia S.F., et al. Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-cancer scales in advanced-stage cancer patients. JClin Epidemiol 2011, 64:507-516.
    • (2011) JClin Epidemiol , vol.64 , pp. 507-516
    • Yost, K.J.1    Eton, D.T.2    Garcia, S.F.3
  • 10
    • 0029775580 scopus 로고    scopus 로고
    • The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial
    • Irvine E.J., Zhou Q., Thompson A.K. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol 1996, 91:1571-1578.
    • (1996) Am J Gastroenterol , vol.91 , pp. 1571-1578
    • Irvine, E.J.1    Zhou, Q.2    Thompson, A.K.3
  • 11
    • 78650167812 scopus 로고    scopus 로고
    • Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index
    • Thia K., Faubion W.A., Loftus E.V., et al. Short CDAI: development and validation of a shortened and simplified Crohn's disease activity index. Inflamm Bowel Dis 2011, 17:105-111.
    • (2011) Inflamm Bowel Dis , vol.17 , pp. 105-111
    • Thia, K.1    Faubion, W.A.2    Loftus, E.V.3
  • 12
    • 0346665816 scopus 로고    scopus 로고
    • Defining relapse of ulcerative colitis using a symptom-based activity index
    • Jowett S.L., Seal C.J., Phillips E., et al. Defining relapse of ulcerative colitis using a symptom-based activity index. Scand J Gastroenterol 2003, 38:164-171.
    • (2003) Scand J Gastroenterol , vol.38 , pp. 164-171
    • Jowett, S.L.1    Seal, C.J.2    Phillips, E.3
  • 13
    • 34547616828 scopus 로고    scopus 로고
    • Utilization of health-care resources by patients with IBD in Manitoba: a profile of time since diagnosis
    • Longobardi T., Bernstein C.N. Utilization of health-care resources by patients with IBD in Manitoba: a profile of time since diagnosis. Am J Gastroenterol 2007, 102:1683-1691.
    • (2007) Am J Gastroenterol , vol.102 , pp. 1683-1691
    • Longobardi, T.1    Bernstein, C.N.2
  • 14
    • 84892704486 scopus 로고    scopus 로고
    • Relative importance measures for reprioritization response shift
    • Lix L.M., Sajobi T.T., Sawatzky R., et al. Relative importance measures for reprioritization response shift. Qual Life Res 2013, 22:695-703.
    • (2013) Qual Life Res , vol.22 , pp. 695-703
    • Lix, L.M.1    Sajobi, T.T.2    Sawatzky, R.3
  • 15
    • 80051536608 scopus 로고    scopus 로고
    • Apopulation-based study of fatigue and sleep difficulties in inflammatory bowel disease
    • Graff L.A., Vincent N., Walker J.R., et al. Apopulation-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 2011, 17:1882-1889.
    • (2011) Inflamm Bowel Dis , vol.17 , pp. 1882-1889
    • Graff, L.A.1    Vincent, N.2    Walker, J.R.3
  • 16
    • 84859262287 scopus 로고    scopus 로고
    • Quality of life, health-related quality of life and health status in patients having restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: a systematic review
    • Heikens J.T., de Vries J., van Laarhoven C.J. Quality of life, health-related quality of life and health status in patients having restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis: a systematic review. Colorectal Dis 2012, 14:536-544.
    • (2012) Colorectal Dis , vol.14 , pp. 536-544
    • Heikens, J.T.1    de Vries, J.2    van Laarhoven, C.J.3
  • 17
    • 84904406236 scopus 로고    scopus 로고
    • Patient preferences for surgical and pharmaceutical treatment of ulcerative colitis: when is surgery better than drugs?
    • Bewtra M, Kilambi V, Siegel CA, et al. Patient preferences for surgical and pharmaceutical treatment of ulcerative colitis: when is surgery better than drugs?. Gastroenterology 2012, 142:S68-S69.
    • (2012) Gastroenterology , vol.142
    • Bewtra, M.1    Kilambi, V.2    Siegel, C.A.3
  • 18
    • 66449088370 scopus 로고    scopus 로고
    • Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management
    • Graff L.A., Walker J.R., Bernstein C.N. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis 2009, 15:1105-1118.
    • (2009) Inflamm Bowel Dis , vol.15 , pp. 1105-1118
    • Graff, L.A.1    Walker, J.R.2    Bernstein, C.N.3
  • 19
    • 84904384862 scopus 로고    scopus 로고
    • 982 Validation of an internet-based cohort of patients with inflammatory bowel diseases (CCFA partners)
    • Randell R.L., Cook S., Wrennall C.E., et al. 982 Validation of an internet-based cohort of patients with inflammatory bowel diseases (CCFA partners). Gastroenterology 2013, 144:S180.
    • (2013) Gastroenterology , vol.144
    • Randell, R.L.1    Cook, S.2    Wrennall, C.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.